European Pharmaceutical Contractor (EPC) is designed to fill a unique position in pharmaceutical publishing. Providing a dedicated platform of communication and information for the international pharmaceutical contract market, it consists of a series of articles and case studies written by eminent figures in contractor groups and traditional multinational pharmaceutical companies.
Each quarterly edition examines areas of importance – both economic and technical – to contract research organisations, contract manufacturers, regulatory controllers, consultants and analysts. This enables regulatory bodies to link directly with policy-makers both in major contractor groups and pharmaceutical companies, and thereby convey regulatory information directly from the governing bodies, but also ensure debate between the policy-makers and consultancy groups.
Dr Graham Hughes,
Published quarterly in
September and December
9-10 February 2015, Holiday Inn Regents Park Hotel, London, UK
regulatory regimes for pharmaceuticals result in significant differences in
pharmaceutical prices across countries. These prices make it profitable for
parallel trade to take place in addition to it reaching a significant
proportion of total national pharmaceutical expenditure in many European
countries. More info >>
CPhI Pharma Insights: India report launched live at CPhI India
CPhI India report
forecasts new MNCs to emerge from India’s pharma SMEs and Japan & Africa as
key export growth markets.
Indian manufacturers evolving up value
chain, concentrating on high-value, low volume work and shifting some R&D
programmes to Western economies. NCE launch predicted in next few years.
More info >>